Elizabeth Jacobs, PhDPfizer has ended its large Phase III Trial of an updated COVID19 vaccine.
They were not able to enroll enough people to meet their goal.
A major problem is the FDA’s wholly unreasonable demand that people with chronic conditions, who benefit most from the vaccine, not be allowed to participate.
David@elizabethjacobs.bsky.social Pfizer will have to move its vaccine trials to another country, and create a partner business headquartered there, at least until the anti-facts regime falls in the USA.